Cancer conference hits stocks

2:16 PM ET Mon, 22 Oct 2018

CNBC's Meg Tirrell reports on a huge flood of news released from a cancer conference in Europe over the weekend that has had a negative impact on a number of biotech stocks. With Dr. Josh Bilenker, Loxo Oncology president & CEO.